We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
-1.9%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$169B
AUM Growth
+$7.91B
Cap. Flow
+$14.7B
Cap. Flow %
8.71%
Top 10 Hldgs %
22.92%
Holding
7,917
New
1,005
Increased
2,598
Reduced
2,429
Closed
906

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$520M
2
NXPI icon
NXP Semiconductors
NXPI
+$248M
3
ORCL icon
Oracle
ORCL
+$242M
4
AMGN icon
Amgen
AMGN
+$197M
5
LLY icon
Eli Lilly
LLY
+$186M

Sector Composition

Rank Sector Weight
1 Financials 8.19%
2 Technology 7.88%
3 Healthcare 6.85%
4 Industrials 5.04%
5 Consumer Discretionary 4.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NNI icon
7276
PUT
Nelnet
NNI
$4.55B
-27,800
Closed -$2.37M
NRDS icon
7277
NerdWallet
NRDS
$632M
-20,237
Closed -$160K
NRDY icon
7278
Nerdy
NRDY
$89.8M
-24,843
Closed -$794K
NRSN icon
7279
NeuroSense Therapeutics
NRSN
$14.2M
-20,259
Closed -$68K
NRXP icon
7280
NRX Pharmaceuticals
NRXP
$154M
-29,682
Closed -$178K
NSPR icon
7281
InspireMD
NSPR
$42.1M
-14,191
Closed -$28K
NTLA icon
7282
CALL
Intellia Therapeutics
NTLA
$1.8B
-10,500
Closed -$543K
NTLA icon
7283
PUT
Intellia Therapeutics
NTLA
$1.8B
-130,500
Closed -$6.75M
NTRA icon
7284
CALL
Natera
NTRA
$47.9B
-16,800
Closed -$595K
NTSX icon
7285
WisdomTree US Efficient Core Fund
NTSX
$1.39B
-26,731
Closed -$891K
NVAX icon
7286
CALL
Novavax
NVAX
$1.47B
-39,000
Closed -$2.01M
NVAX icon
7287
PUT
Novavax
NVAX
$1.47B
-19,100
Closed -$982K
NVNO
7288
enVVeno Medical
NVNO
$7.03M
-304
Closed -$40K
NVS icon
7289
CALL
Novartis
NVS
$302B
-400,000
Closed -$33.8M
NWL icon
7290
PUT
Newell Brands
NWL
$2.59B
-100,000
Closed -$1.9M
NWN icon
7291
Northwest Natural Holdings
NWN
$2.08B
-445,329
Closed -$23.6M
OBIO icon
7292
Orchestra BioMed
OBIO
$322M
-254,466
Closed -$2.53M
ORBS
7293
Eightco Holdings
ORBS
$341M
-363
Closed -$184K
OGN icon
7294
CALL
Organon & Co
OGN
$3.61B
-25,000
Closed -$844K
OKTA icon
7295
CALL
Okta
OKTA
$23.5B
-8,200
Closed -$741K
OMC icon
7296
Omnicom Group
OMC
$24B
-139,463
Closed -$8.87M
OMF icon
7297
PUT
OneMain Financial
OMF
$7.27B
-99,500
Closed -$3.72M
OPEN icon
7298
PUT
Opendoor
OPEN
$3.43B
-523,900
Closed -$2.39M
OPI
7299
DELISTED
Office Properties Income Trust
OPI
-169,838
Closed -$3.39M
ORLA
7300
DELISTED
Orla Mining
ORLA
-38,272
Closed -$105K

Similar funds

Israel Englander's Q3 2022 Portfolio in Review

As of Q3 2022, Israel Englander held 7,917 positions worth $169B, up 4.9% from $161B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Israel Englander deployed $14.7B of net new capital in Q3 2022, opening 1,005 new positions and adding to 2,598 existing holdings. Its largest new stake was Rockwell Automation: 953,525 shares worth $205M.

By sector, the portfolio is most concentrated in Financials at 8.2% of assets, up from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $520M trimmed.

  • Israel Englander's largest Q3 2022 buy was Rockwell Automation: 953,525 shares worth $205M.
  • Israel Englander added most to Duke Realty Corp. in Q3 2022, an estimated $886M increase.
  • Israel Englander's biggest Q3 2022 reduction was Invesco QQQ Trust, cutting an estimated $520M.
  • Israel Englander fully exited Coherent Inc in Q3 2022, selling an estimated $114M.
  • Israel Englander's ten largest holdings make up 23% of its $169B portfolio in Q3 2022.
  • Israel Englander opened 1,005 new positions and closed 906 in Q3 2022.
  • Israel Englander's portfolio value rose 4.9% quarter-over-quarter to $169B.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.